Skip To Main Content
Irving Kirsch on Muck Rack

Irving Kirsch

As seen in: Wiley, PLOS Medicine, BMJ Open, SAGE Publishing, New York Review of Books, The Lancet, Freakonomics., Psychiatric Times, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Irving

Contact Irving, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Restoring STAR*D: A Reanalysis of Drug-Switch Therapy After Failed SSRI Treatment Using Patient-Level Data with Fidelity to the Original STAR*D Research Protocol

|
By Colin Xu, Thomas Kim, Irving Kirsch, Martin Plöderl
| medRxiv
The authors have declared no competing interest. NCT00021528 Funding for this project was provided by the RIAT Support Center and also partially supported by the National Institute of General Medical Sciences under Award Number P20GM104420. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (14) Issue with article?

Why Is Astrology So Popular?

|
By Daniel Kahneman, Irving Kirsch, Angela Duckworth, Mike Maughan
| Freakonomics. Verified
Episode Transcript DUCKWORTH: Don’t worry, I’ve got you covered. Come on in. *      *      * DUCKWORTH: I’m Angela Duckworth. MAUGHAN: I’m Mike Maughan. DUCKWORTH + MAUGHAN: And you’re listening to No Stupid Questions. Today on the show: What’s going on with the rising interest in astrology and the occult? DUCKWORTH: Who is buying crystals around the corner from Angela Duckworth’s house repeatedly?
Open in Who Shared Issue with article?

What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research …

|
By H Edmund Pigott, Thomas Kim, Colin Xu, Irving Kirsch
| BMJ Open Verified
Analytic plan of the RIAT reanalysis We reanalysed the STAR*D patient-level data set with fidelity to the original research protocol wherever possible. Where the protocol was silent, we used other STAR*D publications to guide our analysis. This occurred four times. First, the protocol is silent regarding patients who entered the study without a baseline ROA-administered HRSD score of ≥14.
Open in Who Shared Issue with article?
See all 17 licensed articles (18 Total)